MedPath

The Predictive Factors for Refractory Status and Readmission after Tacrolimus Treatment in Patients with Active Ulcerative Colitis

Not Applicable
Recruiting
Conditions
lcerative Colitis
Registration Number
JPRN-UMIN000009664
Lead Sponsor
Internal Medicine, Lower Gastroenterology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria 1.Patients with serious infectious disease 2.Patients with serious heart disease 3.Patients with serious kidney disease 4.Patients with serious liver disease 5.Patients with diabetes 6.Patients who are pregnant or have the possibility of pregnancy 7.Patients with malignancy 8.Patients who had adverse effect and/or high risk in administration thiopurine 9.Patients who judged as "non-eligible" for this study by responsible doctors

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath